Docosanol

 Docosanol  10%

Cold sore/fever blister treatment

• treats cold sores/fever blisters on the face or lips
• shortens healing time and duration of symptoms:
  • tingling, pain, burning, and/or itching

Allergy Alert

This product may cause a severe allergic reaction. Symptoms may include:

• hives
• facial swelling
• wheezing/difficulty breathing
• shock
• rash

If an allergic reaction occurs, stop use and seek medical help right away.

For external use only

•  if you are allergic to any ingredient in this product

• apply only to the affected areas
• do not use in or near the eyes
• avoid applying directly inside your mouth
• do not share this product with anyone. This may spread the infection.

• your cold sore gets worse or the cold sore is not healed within 10 days

 If swallowed, get medical help or contact a Poison Control Center right away.

• adults and children 12 years or over:
  • wash hands before and after applying cream
  • apply to affected area on the face or lips at the first sign of cold sore/fever blister (tingle).
  • early treatment ensures the best results
  • rub in gently but completely
  • use 5 times a day until healed
• children under 12 years: ask a doctor

• store at 20° to 25°C (68° to 77°F)
• do not freeze

benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate

Call 1-877-753-3935 Monday-Friday 9AM-5PM EST

Compare to the active ingredient in Abreva®†

COLD SORE/FEVER BLISTER TREATMENT

DOCOSANOL CREAM, 10%

Only FDA approved medicine to shorten healing time.*

Cold sore treatment

NET WT OZ (g)

†This product is not manufactured or distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC, distributor of Abreva®.

*Docosanol Cream, 10% contains the only OTC medicine approved by the FDA to shorten healing time and duration of symptoms

RETAIN THIS INSERT FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS.

DISTRIBUTED BY: RITE AID,

200 NEWBERRY COMMONS

ETTERS, PA 17319

[Image in the official label — see DailyMed source]